Doccla, a healthcare startup with a platform capable of monitoring patients in hospital and home departments, has secured $ 3.3 million in seed funding, led by Giant Ventures and Speedinvest. The company allows hospitals to predict when beds will be released by monitoring patients remotely through portable medical devices, helping to alleviate system bottlenecks.
Founded by health entrepreneur Martin Ratz and tech entrepreneur Dag Larrson, Doccla claims to have saved “thousands of bed days for the NHS”, achieving a 29% reduction in emergency admissions and a reduction of 20%. % of A&E attendance, the company said. .
Doccla is similar to competitors Current Health, Huma and Cadence. The latter recently raised $ 41 million in funding from Thrive and General Catalyst. The company offers a remote patient monitoring platform that allows clinicians to monitor patients at home and provide personalized feedback via SMS and “video tours”. Doccla says it can also measure patients at home.
The money collected will be used to invest in its technology and further integrate with portable medical devices and log recording systems. It also plans to expand into European healthcare markets.
Again, as we have seen with other technologies, the development of Doccla has been propelled by the pandemic. As it turned out, overwhelmed hospitals needed technologies like this to create “virtual wards” to monitor patients’ journeys both in and out of the hospital.
said Dag Larsson, CEO and co-founder of Doccla. “Our end-to-end virtual room services are extremely easy for the care provider to support and extremely difficult to ignore. The NHS is now facing a difficult winter season and we are evolving our technology to support healthcare providers. “
He added: “We differ a lot from the competition in that we take care of the entire patient journey (for example, all last mile activities like logistics, customer service and even preconfigured cell phones) . This has allowed us to significantly exceed our weight and win contracts with extremely high approval from patients and clinicians. “
Cameron McLain, Managing Partner and Co-Founder of Giant Ventures added: “Doccla provides a vital solution to a health system under strain, delivering a product that improves the patient experience and lowers costs.
Felix Faltin, Director and Head of Digital Health at Speedinvest, said: “The Doccla platform is more than a product, it is a complete solution that makes healthcare delivery more efficient for providers, cheaper. for payers and safer for patients, long after COVID-19. ”